HB 475

Overall Vote Recommendation
No
Principle Criteria
neutral
Free Enterprise
neutral
Property Rights
negative
Personal Responsibility
negative
Limited Government
negative
Individual Liberty
Digest
HB 475 would require the Texas Health and Human Services Commission (HHSC) to provide Medicaid reimbursement for multisystemic therapy (MST) services delivered by qualified healthcare providers. Specifically, the bill directs HHSC to reimburse providers for services identified under the applicable Healthcare Common Procedure Coding System (HCPCS) code for multisystemic therapy and requires the executive commissioner to establish a distinct Medicaid provider type for MST providers to facilitate enrollment and reimbursement under the Medicaid program.

The bill also includes a standard implementation contingency provision, providing that if federal approval or a waiver is required before implementation, the appropriate state agency must seek that approval and may delay implementation until authorization is granted. This ensures compliance with federal Medicaid requirements while allowing the state to proceed once necessary approvals are obtained.

In practical terms, HB 475 expands Medicaid's reimbursement framework to explicitly recognize multisystemic therapy as a reimbursable service and creates an administrative pathway for providers specializing in MST to participate in the Medicaid program. By establishing a separate provider type, the bill is intended to improve provider enrollment, clarify reimbursement procedures, and increase access to intensive behavioral health services for Medicaid recipients who may benefit from evidence-based multisystemic therapy.
Fiscal Notes

According to the Legislative Budget Board (LBB), HB 475 would have a negative fiscal impact of approximately $4.1 million in General Revenue-related funds during the 2026–27 biennium. The bill would require the Health and Human Services Commission (HHSC) to create a new Medicaid benefit for multisystemic therapy (MST) services and establish a separate provider type for reimbursement. Although the bill takes effect September 1, 2025, HHSC estimates that implementation would take 12 to 18 months because of required policy revisions, rate setting, and system updates, with services beginning September 1, 2026.

The primary fiscal driver is the cost of providing the new Medicaid benefit. HHSC estimates an average monthly caseload of approximately 1,094 recipients in fiscal year 2027, growing to more than 2,100 recipients by fiscal year 2030, at an estimated annual cost of $10,821 per recipient. While some of these costs would be offset by reduced utilization of other mental health services and modest increases in insurance premium tax revenue, the net effect remains a continuing increase in state Medicaid expenditures. General Revenue costs are projected to rise from $3.8 million in fiscal year 2027 to approximately $7.1 million annually by fiscal year 2030, indicating that the fiscal impact is ongoing rather than one-time.

The bill also requires upfront administrative and technology investments. HHSC estimates one-time technology and implementation costs of $1.6 million (All Funds) in fiscal year 2026, including system modifications and establishment of the new provider type, followed by approximately $115,500 annually for ongoing system maintenance and updates.

The LBB further concludes that the legislation would not have a significant fiscal impact on local governments. The anticipated costs are borne primarily by the state Medicaid program, with federal Medicaid matching funds covering a substantial share of total expenditures while General Revenue finances the state's matching obligation.

Vote Recommendation Notes

HB 475 seeks to expand access to evidence-based behavioral health treatment by requiring the Health and Human Services Commission (HHSC) to provide Medicaid reimbursement for multisystemic therapy (MST) services and establish a dedicated provider type for those delivering the treatment. While the bill is intended to improve outcomes for high-risk youth and reduce reliance on more costly interventions, it accomplishes those objectives by expanding the Medicaid program through a new statutory benefit mandate.

From a limited-government perspective, the bill increases the size and scope of state government by permanently expanding Medicaid coverage and requiring HHSC to administer an additional provider classification and reimbursement program. Although the legislation does not create a new agency or impose significant new regulations on private individuals or businesses, it establishes a continuing government obligation to finance a specific healthcare service. The LBB estimates the bill will increase General Revenue expenditures by approximately $4.1 million during the 2026–27 biennium, with annual costs exceeding $7 million in future years, creating an ongoing burden on taxpayers without a sunset provision or other meaningful limitation on future program growth.

The bill also establishes a precedent for legislatively mandating Medicaid reimbursement for specific therapies, which could encourage future benefit expansions through statute rather than allowing policymakers to evaluate Medicaid services as part of a comprehensive budget and policy process. While multisystemic therapy may provide meaningful clinical benefits, those potential outcomes do not outweigh the long-term implications of expanding a taxpayer-funded entitlement program. For lawmakers committed to limiting the growth of government, restraining recurring public expenditures, and preserving legislative flexibility over Medicaid policy, the recommendation is Vote No.

  • Individual Liberty: The bill modestly expands government involvement in healthcare by requiring taxpayers to finance an additional Medicaid benefit. While it does not impose new mandates or restrictions on individual conduct, it increases the state's role in providing and directing healthcare services, resulting in a modest reduction in individual liberty through expanded government activity.
  • Personal Responsibility: The bill expands reliance on a taxpayer-funded entitlement program rather than encouraging private payment, charitable assistance, or other non-government solutions for behavioral health treatment. Although the target population consists of Medicaid recipients, the legislation reinforces dependence on public financing rather than individual, family, or community responsibility for obtaining services.
  • Free Enterprise: The bill does not impose new regulations, licensing requirements, or compliance costs on private businesses or healthcare providers. Participation in Medicaid remains voluntary, and providers that choose to enroll may benefit from an additional reimbursement opportunity. However, by expanding publicly financed healthcare, the bill modestly shifts demand toward government-funded services rather than private markets. On balance, the direct impact on free enterprise is limited and best characterized as neutral.
  • Private Property Rights: The bill does not affect the ownership, use, transfer, or regulation of private property. It neither authorizes takings nor creates new restrictions on property owners, leaving private property rights unaffected.
  • Limited Government: The bill permanently expands the scope of Medicaid by creating a new statutory reimbursement requirement and directing the Health and Human Services Commission to establish and administer a new provider classification. It also increases recurring taxpayer expenditures, with the Legislative Budget Board estimating a negative General Revenue impact of approximately $4.1 million during the 2026–27 biennium and continuing annual costs thereafter. Because the legislation enlarges the responsibilities of state government and creates an ongoing spending commitment without a sunset or limiting mechanism, it has a clear negative impact on the principle of limited government.
View Bill Text and Status